original ) (raw )Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin
Neel Vaidya
Diabetes, Obesity and Metabolism
View PDFchevron_right
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
Franz-Werner Dippel
Diabetes, metabolic syndrome and obesity : targets and therapy, 2015
View PDFchevron_right
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
Rory McCrimmon
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018
View PDFchevron_right
Glycemic Response and Attainment of A1C Goals Following Newly Initiated Insulin Therapy for Type 2 Diabetes
Kimberly Brodovicz , Tzuyung Kou
Diabetes Care, 2012
View PDFchevron_right
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Jean-françois Yale
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018
View PDFchevron_right
A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin
Fernando J - Lavalle-González
Diabetes/Metabolism Research and Reviews, 2016
View PDFchevron_right
Initiating basal insulin therapy in patients with type 2 diabetes mellitus
Kent Stoneking
American Journal of Health-system Pharmacy, 2005
View PDFchevron_right
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
Brian Frier
Diabetes, Obesity and Metabolism, 2018
View PDFchevron_right
Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials
David Owens
Primary care diabetes, 2015
View PDFchevron_right
A global study of the unmet need for glycaemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin
Fernando Lavalle-González
Diabetes/Metabolism Research and Reviews, 2016
View PDFchevron_right
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
Wolfgang Landgraf
Diabetes Care, 2009
View PDFchevron_right
Commencing insulin glargine 100 U/mL therapy in people with type 2 diabetes: Determinants of achievement of HbA1c goal <7.0%
David Owens
Diabetes, Obesity and Metabolism
View PDFchevron_right
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
Edward Jude
Diabetes Therapy, 2019
View PDFchevron_right
Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: A systematic review
Paolo Chiodini
Diabetes Research and Clinical Practice, 2011
View PDFchevron_right
The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: Results from the A1chieve observational study
Zanariah Hussein , Zafar Latif
Diabetes Research and Clinical Practice, 2013
View PDFchevron_right
When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study
S. Guler
International Journal of Clinical Practice, 2008
View PDFchevron_right
Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
bruno detournay
Diabetes Therapy, 2020
View PDFchevron_right
A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment Failure
Philip Raskin
Endocrine Practice, 2011
View PDFchevron_right
Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
Paolo Chiodini
Diabetes Care, 2011
View PDFchevron_right
Addressing barriers to effective basal insulin therapy
Mathew John
The Journal of the Association of Physicians of India, 2014
View PDFchevron_right
Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes
Poul Strange
Diabetes Care, 2006
View PDFchevron_right
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: a pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials
David Owens
Diabetes research and clinical practice, 2014
View PDFchevron_right
Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
Martin Pfohl
Vascular Health and Risk Management, 2015
View PDFchevron_right
Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice
Björn Eliasson
Diabetes Therapy, 2014
View PDFchevron_right
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
Andrew Hockey
Diabetes, Obesity and Metabolism, 2015
View PDFchevron_right
Achieve Control: A pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes
Bryan Johnstone
Postgraduate medicine, 2016
View PDFchevron_right
Control of Glycemia With a Basal-Plus Regimen in People With Type 2 Diabetes Mellitus Insufficiently Controlled by Previous Treatment
Hinde Iraqi
Journal of Endocrinology and Metabolism
View PDFchevron_right
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents
Wolfgang Landgraf
Diabetes Care, 2009
View PDFchevron_right
CLINICAL OUTCOMES AFTER SWITCHING FROM PREMIXED INSULIN TO BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN EVERYDAY CARE IN THE GULF REGION: THE I-TALENT STUDY.
IJAR Indexing
View PDFchevron_right
Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis
Franz-Werner Dippel
Primary Care Diabetes, 2015
View PDFchevron_right